Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10934795 | 0.83 | TP53 (0.43) | SMN1; SMN2CA1CA2CA9HTT | |
| SCHEMBL11421035 | 0.82 | CYP3A4 (0.47) | SMN1; SMN2 | |
| SCHEMBL1009556 | 0.81 | SMN1; SMN2 (0.39) | SMN1; SMN2CA1CA2CA9HTT | |
| SCHEMBL6313898 | 0.80 | SMN1; SMN2 (0.33) | SMN1; SMN2 | |
| SCHEMBL31050159 | 0.79 | SMN1; SMN2 (0.38) | SMN1; SMN2CA1CA2CA9HTT | |
| SCHEMBL31050154 | 0.79 | SMN1; SMN2 (0.38) | SMN1; SMN2CA1CA2CA9HTT | |
| SCHEMBL575208 | 0.77 | SMN1; SMN2 (0.38) | SMN1; SMN2CA1CA2CA9HTT | |
| SCHEMBL16423919 | 0.75 | MEN1 (0.47) | — | |
| SCHEMBL2782186 | 0.74 | TP53 (0.39) | TP53TDP1 | |
| SCHEMBL576397 | 0.74 | SMN1; SMN2 (0.37) | SMN1; SMN2CA1CA2CA9HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4730479-A2 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | Kyoto University (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-20250246685-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | KYOTO UNIVERSITY (JP) | 2025-07-31 | — | — | US | disclosed |
| EP-4428982-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | Kyoto University (JP) | 2024-09-11 | — | — | EP | disclosed |
| CN-114685556-A | Preparation method of monofluorophosphate | 浙江蓝天环保高科技股份有限公司 | 2022-07-01 | — | — | CN | disclosed |
| EP-3222624-B1 | IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME | CENTRAL GLASS CO LTD (JP) | 2019-11-06 | — | — | EP | disclosed |
| US-10287165-B2 | Imidic acid compound having divalent anion and process for producing the same | CENTRAL GLASS CO., LTD. (JP) | 2019-05-14 | — | — | US | disclosed |
| EP-2832737-B1 | FLUORINE-CONTAINING PHOSPHATE ESTER-AMIDE, AND FLAME RETARDANT RESIN, FLAME RETARDANT LIQUID AND FLAME RETARDANT SOLVENT FOR ORANIC SYNTHESIS CONTAINING SAME | TOSOH FINECHEM CORP (JP) | 2018-08-01 | — | — | EP | disclosed |
| US-9879037-B2 | Fluorine-containing phosphate ester-amide, and flame retardant resin, flame retardant liquid and flame retardant solvent for organic synthesis containing same | TOSOH F-TECH, INC. (JP) | 2018-01-30 | — | — | US | disclosed |
| EP-3222624-A1 | IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME | Central Glass Co., Ltd. (JP) | 2017-09-27 | — | — | EP | disclosed |
| US-20170267528-A1 | IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME | CENTRAL GLASS CO., LTD. (JP) | 2017-09-21 | — | — | US | disclosed |
| US-20150053901-A1 | FLUORINE-CONTAINING PHOSPHATE ESTER-AMIDE, AND FLAME RETARDANT RESIN, FLAME RETARDANT LIQUID AND FLAME RETARDANT SOLVENT FOR ORGANIC SYNTHESIS CONTAINING SAME | TOSOH F- TECH, INC. (JP) | 2015-02-26 | — | — | US | disclosed |
| EP-2832737-A1 | FLUORINE-CONTAINING PHOSPHATE ESTER-AMIDE, AND FLAME RETARDANT RESIN, FLAME RETARDANT LIQUID AND FLAME RETARDANT SOLVENT FOR ORANIC SYNTHESIS CONTAINING SAME | Tosoh F-Tech, Inc. (JP) | 2015-02-04 | — | — | EP | disclosed |
| EP-0460045-A1 | NUCLEOSIDE ANALOGUES | UNIVERSITY COLLEGE LONDON (GB) | 1991-12-11 | — | — | EP | disclosed |
| WO-1990010012-A1 | NUCLEOSIDE ANALOGUES | UNIVERSITY COLLEGE LONDON (GB) | 1990-09-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150053901-A1 | FLUORINE-CONTAINING PHOSPHATE ESTER-AMIDE, AND FLAME RETARDANT RESIN, FLAME RETARDANT LIQUID AND FLAME RETARDANT SOLVENT FOR ORGANIC SYNTHESIS CONTAINING SAME | AFF1, RER1, AFF2 | SMN1; SMN2 2110/4885CA1 933/4885CA2 1035/4885 |
| US-20170267528-A1 | IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME | CA2, CA6, CHRM1 | SMN1; SMN2 2964/4885CA1 7/4885CA2 1/4885 |
| US-10287165-B2 | Imidic acid compound having divalent anion and process for producing the same | CA2, CA6, CHRM1 | SMN1; SMN2 2964/4885CA1 7/4885CA2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.